Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-015614
Filing Date
2009-03-23
Accepted
2009-03-23 16:03:11
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v143271_10k.htm 10-K 1196590
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 v143271_ex23-1.htm EX-23.1 2819
5 v143271_ex31-1.htm EX-31.1 15854
6 v143271_ex31-2.htm EX-31.2 15738
7 v143271_ex32-1.htm EX-32.1 6686
8 v143271_ex32-2.htm EX-32.2 7182
  Complete submission text file 0001144204-09-015614.txt   1246774
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 617-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33038 | Film No.: 09698871
SIC: 8093 Services-Specialty Outpatient Facilities, NEC